In a series of 15 clinical cases, Saad et al. [25] reported that hypogonadal men with psoriasis treated with testosterone for a long period of time demonstrated significant benefits in reduced psoriasis area and reduced severity index (PASI), as well as physician global assessment for psoriasis (PGA) and reduced CRP levels. The gene discussed is CRP; the disease is psoriasis.